This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Warren Buffett's 5 Favorite Stocks for 2013

DaVita HealthCare Partners

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

DaVita HealthCare Partners ( DVA) remains one of Ted Weschler's favorite stocks in 2013. The portfolio manager added 1.37 million shares of the dialysis center operator to Berkshire Hathaway's portfolio in the first quarter, adding onto his existing stake by 10%. That brings Berkshire's total position in DVA to 14% of outstanding shares.

>>3 Health Care Stocks Spiking on Big Volume

There's a limit on how much Weschler can buy. Earlier this month, he agreed to limit Berkshire's stake in DaVita to 25%, and limit his shareholder activism in the firm. That news quelled rumors that DVA could be a buyout target for Berkshire, but this quarter's position increase shows that Berkshire's investment team is still bullish on this business.

DaVita runs more than 1,800 clinics and in-patient hospital dialysis units across the U.S. The firm's clinics are unique in that they serve patients who suffer from chronic long-term kidney issues. Typically, the only way around dialysis is a kidney transplant, and demand vastly outstrips supply of transplant organs in this country. That means that DVA's nearly 140,000 patients are likely to stick with its facilities for the long-term. Health care tends to be a sticky business -- barring a major bad experience, patients are likely to stay with their providers -- which makes DVA's revenues consistent and predictable in large part.

The 2012 merger with HealthCare Partners changes DVA's concentration slightly. The new physician management arm now makes up around a quarter of DaVita's revenues. That increased scale justifies the increased share price that investors are paying for DVA. I'd expect Berkshire's buying of DVA to keep on going in 2013.

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CBI $46.16 0.00%
DTV $88.60 0.00%
DVA $74.60 0.00%
STRZA $33.24 0.00%
VRSN $64.02 0.00%


DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs